Break Through Designation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Break Through Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Break Through Designation Today - Breaking & Trending Today

Theralase(R) Expands Clinical Team

Published: May 2, 2024

TORONTO, ON / ACCESSWIRE / May 2, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light

Source: eagletribune.com

Abbisko Therapeutic announces that EMA has granted orphan drug designation for its CSF-1R inhibitor Pimicotinib （ABSK021）

Published: January 9, 2024

/PRNewswire/ -- On January 9, 2024 (Beijing Time), Abbisko Therapeutics (HKEX code: 02256) announced that its investigational innovative CSF-1R inhibitor...

Source: prnewswire.com

Theralase® Releases FY2022 Audited Financial Statements

Published: April 26, 2023

TORONTO, April 26, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage...

Source: globenewswire.com

Theralase Releases Q322 Interim Financial Statements

Published: November 30, 2022

30.11.2022 - TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) - Theralase Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic ...

Source: wallstreet-online.de

Team Arnav Foundation Partners with OS Therapies Supporting the Phase IIb Trial of OST-HER2 (Listeria monocytogenes) in Recurred, Resected Osteosarcoma

Published: September 22, 2022

/PRNewswire/ -- OS Therapies, a research and clinical-stage biopharmaceutical company and Team Arnav Foundation, a non-profit 501c3 organization focused on...